The Cytogenetic Market is estimated at $ 1,111 million
in 2017 and is expected to reach $ 399 million in 2025, with an average annual
growth rate of 13.5% from 2018 to 2025.
Cytogenetics is a field of biology that links
cytology and genetics. Correlation is used to study the chromosomes and genes
of cells and tissues. This work is done in relation to the number of
chromosomes used in gene mutation and mutation and in the selection of the
correct treatment for the detection of genetic diseases and the treatment of
these genetic disorders. Cytogenetics includes a variety of techniques
including comparative genomic hybridization, fluorescence in situ
hybridization, karyotyping, and immunohistochemistry. These techniques require
the use of cytogenetic agents such as test kits, media and reagents. Probe; Expendables;
instrument; and software and services. These products and technologies are used
in the screening of genetic diseases and in the design of personal medicine.
Along with the proliferation of chronic diseases,
an increase in the prevalence of cancer and hereditary diseases, an increase in
the global elderly population, and a surge in awareness of the worldwide
acceptance of customized medicines are leading factors in the growth of the
global cytogenetics market. But the high cost of advanced cytogenetics
equipment is expected to hamper market growth. Conversely, the transition from
fish to array-based technology is expected to provide many opportunities during
the forecast period.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2116
The utilization rate of testing kits, media, and reagents is high, as they are the essential elements of every cytogenetic technique performed. However, the software & services segment is expected to grow at a high CAGR during the forecast period.
The key players of this market
include
·
Abbott Laboratories
·
Agilent
Technologies Inc.
·
Applied Spectral
Imaging Inc.
·
Empire Genomics
LLC.
·
Illumina Inc.
·
Irvine Scientific.
·
OPKO Health Inc.
(GeneDx.)
·
PerkinElmer Inc.
·
Sysmex Corporation
(Oxford Gene Technology)
·
Thermo Fisher
Scientific Inc.
Other players (these players are not
profiled in the report and the same can be included on request) in the value
chain include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and
MetaSystems.
Get Discount UP To 25% * Offer Till 31st
Dec 2018@ https://www.alliedmarketresearch.com/checkout/570017
The comparative genomic hybridization
segment is the largest segment in the global cytogenetics market, and is
anticipated to grow at a high CAGR during the forecast period. The clinical
& research laboratories segment is expected to grow at a moderate CAGR in
the near future. On the other hand, the pharmaceutical & biotechnology
companies segment is anticipated to record a high CAGR during the forecast
period.
Key findings of the Cytogenetics Market:
- The testing kits, media, and
reagents segment accounted for approximately three-fourths share of the
global cytogenetics consumables market in 2017.
- The comparative genomic
hybridization segment is expected to grow at a CAGR of 10.5% from 2018 to
2025.
- North America accounted for
the majority of the share of the global market revenue in 2017.
- Asia-Pacific is expected to
provide lucrative market growth opportunities, registering a CAGR of 12.1%
from 2018 to 2025.
North America was the leading revenue
contributor to the global cytogenetics market in 2017, and is expected to
dominate the market during the forecast period. This is attributed to the
presence of majority of major key players in this region. However, Asia-Pacific
is expected to grow at the highest CAGR during the forecast period, owing to
increase in affordability, surge in healthcare expenditure, and rise in
awareness towards early screening of genetic disorders.
Access Full Summery @ https://www.alliedmarketresearch.com/cytogenetics-market
No comments:
Post a Comment